SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
30-Dec-22 4:58 PM View: | Athira Pharma, Inc. (ATHA) | 28-Dec-22 | Purchase | 50,000 | $2.85 | $142,250.00 | 45% 109.93K to 159.93K | |
30-Dec-22 4:58 PM View: | Athira Pharma, Inc. (ATHA) | 18-Nov-22 | Grant | 763 | $2.74 | $2,090.62 | < 1% 109.17K to 109.93K | |
24-Jun-22 7:53 PM View: | Athira Pharma, Inc. (ATHA) | 23-Jun-22 | Sale | 2,614 | $2.69 | $7,031.66 | (2%) 111.78K to 109.17K | |
24-Jun-22 7:53 PM View: | Athira Pharma, Inc. (ATHA) | 22-Jun-22 | Grant | 10,000 | -- | -- | 10% 101.78K to 111.78K | |
24-Jun-22 7:53 PM View: | Athira Pharma, Inc. (ATHA) | 18-May-22 | Grant | 1,721 | $7.06 | $12,150.30 | 2% 100.06K to 101.78K | |
12-Apr-22 7:36 PM View: | Athira Pharma, Inc. (ATHA) | 11-Apr-22 | Option Exercise | 3,000 | $10.64 | $31,920.00 | 3% 97.06K to 100.06K | 8% |
06-Jan-22 5:08 PM View: | Athira Pharma, Inc. (ATHA) | 04-Jan-22 | Option Exercise | 6,305 | $1.35 | $8,511.75 | 7% 90.75K to 97.06K | |
06-Jan-22 5:08 PM View: | Athira Pharma, Inc. (ATHA) | 18-Nov-21 | Grant | 931 | $12.51 | $11,646.80 | 1% 89.82K to 90.75K | |
10-Jun-21 6:48 PM View: | Athira Pharma, Inc. (ATHA) | 10-Jun-21 | Option Exercise | 6,305 | $1.35 | $8,511.75 | 8% 83.52K to 89.82K | |
10-Jun-21 6:48 PM View: | Athira Pharma, Inc. (ATHA) | 18-May-21 | Grant | 1,554 | $14.45 | $22,455.30 | 2% 81.97K to 83.52K |